Published in Hepatology on March 19, 1986
[Trial of device that is not approved or cleared by the U.S. FDA] | NCT01851252
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut (2015) 1.20
Current management of the complications of portal hypertension: variceal bleeding and ascites. CMAJ (2006) 1.10
Comparison of three methods of nutritional assessment in liver cirrhosis: subjective global assessment, traditional nutritional parameters, and body composition analysis. J Gastroenterol (2006) 0.99
Clinical pharmacology of portal hypertension. Gastroenterol Clin North Am (2010) 0.92
The extent of the collateral circulation influences the postprandial increase in portal pressure in patients with cirrhosis. Gut (2006) 0.91
Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research. J Pediatr Gastroenterol Nutr (2011) 0.84
Hemodynamic effects of one week of carvedilol administration on cirrhotic rats. J Gastroenterol (2006) 0.81
Efficacy of beta-adrenergic blocker plus 5-isosorbide mononitrate and endoscopic band ligation for prophylaxis of esophageal variceal rebleeding: a meta-analysis. World J Gastroenterol (2009) 0.80
Hepatic venous pressure gradient: worth another look? Dig Dis Sci (2008) 0.80
Chronic splanchnic hemodynamic effects of spironolactone with unrestricted sodium diet in patients with compensated cirrhosis. Dig Dis Sci (1998) 0.79
Pathophysiology of portal hypertension and its clinical links. J Clin Exp Hepatol (2011) 0.79
Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease. Gut (2001) 0.78
Chronic splanchnic hemodynamic effects of low-dose transdermal nitroglycerin versus low-dose transdermal nitroglycerin plus spironolactone in patients with cirrhosis. Dig Dis Sci (1997) 0.78
Primary prevention of variceal bleeding: pharmacological therapy versus endoscopic banding. N Am J Med Sci (2013) 0.78
Nutritional status assessment in cirrhotic patients after protein supplementation. ISRN Gastroenterol (2012) 0.78
Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers. Am J Gastroenterol (2016) 0.75
The effect of propranolol in malay patients with liver cirrhosis - a pharmacodynamic evaluation. Malays J Med Sci (2003) 0.75
Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients. Gut (1998) 0.75
Diagnosing bacterial peritonitis made easy by use of leukocyte esterase dipsticks. Int J Crit Illn Inj Sci (2015) 0.75
Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance Angiography. Biomed Res Int (2017) 0.75
Propranolol in the primary prevention of upper gastrointestinal tract haemorrhage in patients with cirrhosis of the liver and oesophageal varices. Drugs (1989) 0.75
The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods. Control Clin Trials (1985) 6.22
Health care workers' ability and willingness to report to duty during catastrophic disasters. J Urban Health (2005) 4.15
International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet (2009) 3.89
Nonassociation of adrenocorticosteroid therapy and peptic ulcer. N Engl J Med (1976) 3.19
Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology (1990) 2.99
TIPS: the long and short of it. Gastroenterology (1997) 2.54
Liver disease associated with secondary syphilis. N Engl J Med (1971) 2.51
A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology (1989) 2.40
Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol (1999) 2.39
The present status of shunts for portal hypertension in cirrhosis. Gastroenterology (1966) 2.38
Spontaneous bacterial peritonitis in cirrhosis: variations on a theme. Medicine (Baltimore) (1971) 2.26
Deficiency of protein C in patients with portal vein thrombosis. Hepatology (1988) 2.19
Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis (1977) 2.15
Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology (1977) 2.10
Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology (1985) 2.09
Branched-chain amino acids in the management of hepatic encephalopathy: an analysis of variants. Hepatology (1989) 2.05
Prophylactic portacaval anastomosis. Medicine (Baltimore) (1972) 1.99
T cell-mediated maintenance of natural self-tolerance: its breakdown as a possible cause of various autoimmune diseases. J Autoimmun (1996) 1.93
Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut (2005) 1.93
Outpatient liver biopsy: how safe is it? Ann Intern Med (1993) 1.90
Improved method for bacteriological diagnosis of spontaneous bacterial peritonitis. J Clin Microbiol (1989) 1.90
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology (1983) 1.67
Preoperative evaluation of patients for liver resection. Appropriate CT imaging. Ann Surg (1993) 1.65
A rational approach to the hepatorenal syndrome. Gastroenterology (1973) 1.63
Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. Gastroenterology (1999) 1.58
Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology (1994) 1.56
Vasodilatation and sodium retention in prehepatic portal hypertension. Gastroenterology (1992) 1.53
Wedged and free hepatic venous pressure measured with a balloon catheter. Gastroenterology (1979) 1.52
Therapeutic portacaval anastomosis: to shunt or not to shunt. Gastroenterology (1974) 1.50
Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres. Am J Physiol (1981) 1.50
Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol (1997) 1.48
Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis (1978) 1.47
Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology (1998) 1.47
Distal splenorenal vs. portal-systemic shunts after hemorrhage from varices: a randomized controlled trial. Hepatology (1988) 1.45
Ammonia tolerance in the diagnosis of esophageal varices. A comparison of endoscopic, radiologic, and biochemical techniques. J Lab Clin Med (1967) 1.43
A perspective on emergency portacaval shunt. Hepatology (1994) 1.41
Diazepam and breast-feeding. Lancet (1972) 1.41
Transjugular intrahepatic portosystemic shunts versus sclerotherapy: a discussion of discordant results. Ann Intern Med (1997) 1.40
Evidence for x-linked dominant inheritance of ornithine transcarbamylase deficiency. N Engl J Med (1973) 1.37
Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol (1983) 1.37
Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology (1996) 1.35
Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial. N Engl J Med (1969) 1.35
A peek at the Child-Turcotte classification. Hepatology (1982) 1.34
Esophageal tamponade in the treatment of bleeding varices. A decadel progress report. Dig Dis Sci (1980) 1.34
Macrophage extrinsic antiviral activity during herpes simplex virus infection. J Gen Virol (1980) 1.34
Increased blood flow through the portal system in cirrhotic rats. Gastroenterology (1984) 1.30
Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting. N Engl J Med (1974) 1.29
Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective, controlled clinical trial. Gastroenterology (1975) 1.28
Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol (1985) 1.28
Spontaneous bacterial peritonitis in cirrhosis: endemic or epidemic? Med Clin North Am (1975) 1.27
Properties of new, long-wavelength, voltage-sensitive dyes in the heart. J Membr Biol (2005) 1.26
Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J Clin Invest (1999) 1.24
A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology (1995) 1.24
Distal splenorenal shunt vs. portal-systemic shunt: current status of a controlled trial. Hepatology (1981) 1.24
Selective intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage. Gastroenterology (1972) 1.23
Increased incidence of cholelithiasis in Laënnec's cirrhosis. A postmortem evaluation of pathogenesis. Gastroenterology (1972) 1.22
Ideal treatment of portal hypertension in 1985. Clin Gastroenterol (1985) 1.21
Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology (1993) 1.20
Pseudoaneurysm: a complication of faulty technique in femoral arterial puncture. Radiology (1985) 1.20
Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J Clin Invest (1997) 1.20
Iron storage disorders of the liver. Gastroenterology (1974) 1.17
Portal-systemic encephalopathy and portacaval anastomosis: a prospective, controlled investigation. Gastroenterology (1974) 1.16
Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology (1995) 1.15
Correlation of Doppler US tumor signals with neovascular morphologic features. Radiology (1988) 1.15
Distal spleno-renal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. A meta-analysis of 4 randomized clinical trials. J Hepatol (1992) 1.14
Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group. Hepatology (1991) 1.13
Colchicine in the treatment of cirrhosis of the liver. N Engl J Med (1988) 1.13
Macrophage functions in beige (Chédiak-Higashi syndrome) mice. Cancer Res (1980) 1.11
Observer variability in echo-Doppler measurements of portal flow in cirrhotic patients and normal volunteers. Gastroenterology (1990) 1.11
Somatostatin in portal hypertension. Dig Dis Sci (1989) 1.10
Effect of portacaval anastomosis on hypersplenism. Dig Dis Sci (1980) 1.09
Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment? Hepatology (2001) 1.09
Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution. Gastroenterology (1986) 1.09
The syndrome of methoxyflurane-associated hepatitis. Ann Intern Med (1974) 1.08
Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal-hypertensive rats. Hepatology (1992) 1.08
The clinical significance and natural history of the double pylorus. Dig Dis Sci (1984) 1.08
Enhanced release of nitric oxide in response to changes in flow and shear stress in the superior mesenteric arteries of portal hypertensive rats. Hepatology (1998) 1.07
Percutaneous versus peritoneoscopic liver biopsy. Gastroenterology (1972) 1.07
Innovative information-sharing strategies. Emerg Infect Dis (1998) 1.07
Congenital absence of the portal vein in oculoauriculovertebral dysplasia (Goldenhar syndrome). Pediatr Radiol (1986) 1.07
Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment. Semin Liver Dis (1986) 1.07